WCM
TMO icon

Westend Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Westend Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14
Closed -$8.11K – 276
2025
Q4 		$8.11K Hold
14
– – ﹤0.01% 169
2025
Q3 		$6.79K Hold
14
– – ﹤0.01% 165
2025
Q2 		$5.68K Hold
14
– – ﹤0.01% 162
2025
Q1 		$6.97K Hold
14
– – ﹤0.01% 134
2024
Q4 		$7.28K Hold
14
– – ﹤0.01% 140
2024
Q3 		$8.66K Hold
14
– – ﹤0.01% 139
2024
Q2 		$7.58K Hold
14
– – ﹤0.01% 120
2024
Q1 		$8.14K Buy
+14
New +$7.86K ﹤0.01% 138

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westend Capital Management's TMO Position: Q1 2026 in Review

Westend Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 14 shares — an estimated $8.11K sold.

Westend Capital Management first reported a position in TMO in Q1 2024 and held it in 8 quarters. The position peaked at $8.66K in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Westend Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Westend Capital Management sold 14 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.11K.
  • Westend Capital Management first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 8 quarters.
  • Westend Capital Management's Thermo Fisher Scientific position peaked at $8.66K in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.